Clinical Trials Using Anti-CD25-PBD Antibody-drug Conjugate ADCT-301
Clinical trials are research studies that involve people. The clinical trials on this list are studying Anti-CD25-PBD Antibody-drug Conjugate ADCT-301. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
This study evaluates ADCT-301 in patients with Selected Advanced Solid Tumors. Patients will participate in a Treatment Period with 3-week cycles and a Follow-up Period every 12 weeks for up to 1 year after treatment discontinuation.
Location: 3 locations